COM:ACTINIUMPHARMA
Actinium Pharmaceuticals, Inc.
- Stock
Last Close
1.47
22/11 21:00
Market Cap
210.57M
Beta: -
Volume Today
222.68K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 638.00K - | 1.33M 108.68% | 1.88M 41.12% | 2.83M 50.86% | 4.41M 55.59% | 5.22M 18.36% | 2.91M 44.31% | 2.17M 25.35% | 2.17M 0% | 5.07M - | ||
average receivables | ||||||||||||
book value per share | -2.06 - | -2.11 2.50% | 17.28 919.64% | 11.15 35.47% | 6.14 44.88% | 2.49 59.42% | 1.13 54.50% | 5.05 345.47% | 3.58 29.24% | 2.75 22.98% | 136.74 4,865.60% | |
capex per share | -0.02 - | -0.17 660.17% | -0.04 77.41% | -0.04 1.21% | -0.01 70.04% | -0.03 144.49% | -0.01 52.77% | -0.02 62.37% | -0.01 68.99% | -0.02 134.46% | -0.58 3,693.40% | |
capex to depreciation | -10.64 - | -4.00 62.38% | -0.89 77.66% | -0.77 13.47% | -0.44 42.82% | -1.89 328.38% | -0.15 91.97% | -0.57 272.14% | -0.25 55.16% | -0.52 106.29% | -0.19 63.01% | |
capex to operating cash flow | 0.00 - | 0.01 300.92% | 0.00 75.62% | 0.00 11.92% | 0.00 60.20% | 0.00 306.97% | 0.00 36.27% | 0.01 293.13% | 0.01 45.54% | -0.04 764.28% | 0.00 107.63% | |
capex to revenue | -0.12 - | -0.36 205.65% | -1.89 431.57% | |||||||||
cash per share | 7.30 - | 7.37 0.95% | 20.16 173.72% | 12.70 37.00% | 7.82 38.43% | 3.87 50.54% | 1.86 51.92% | 5.24 181.65% | 3.78 27.76% | 4.51 19.22% | 288.22 6,288.74% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 33.56K - | |||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.03 - | 0.04 36.86% | 0.01 73.32% | 0.02 - | 0.12 593.86% | 0.01 90.92% | 0.00 65.31% | 0.02 486.11% | 0.03 14.78% | |||
debt to equity | -0.10 - | -0.15 45.74% | 0.01 108.20% | 0.03 - | 0.25 749.13% | 0.01 95.24% | 0.00 64.98% | 0.04 821.05% | 0.06 49.61% | |||
dividend yield | 0.00 - | 0.00 72.94% | ||||||||||
earnings yield | -0.08 - | -0.15 90.53% | -0.17 11.37% | -0.57 236.22% | -0.60 4.71% | -0.58 4.03% | -0.67 15.99% | -0.23 65.18% | -0.20 14.59% | -0.12 37.55% | -36.12 28,986.07% | |
enterprise value | 128.64M - | 154.75M 20.30% | 97.87M 36.75% | 21.89M 77.64% | 26.89M 22.88% | 27.63M 2.73% | 24.67M 10.70% | 31.83M 29.00% | 46.10M 44.84% | 150.78M 227.09% | -73.21M 148.56% | |
enterprise value over ebitda | -19.53 - | -6.90 64.70% | -3.95 42.71% | -0.82 79.30% | -0.99 21.12% | -1.16 17.34% | -1.14 1.94% | -1.45 27.27% | -1.89 30.06% | -4.51 139.31% | 1.41 131.24% | |
ev to operating cash flow | -20.44 - | -10.78 47.25% | -5.28 51.06% | -1.05 80.05% | -1.25 18.52% | -1.34 7.64% | -1.15 14.41% | -1.47 28.07% | -2.21 50.06% | 17.44 889.57% | 1.55 91.13% | |
ev to sales | 40.29 - | 146.39 263.29% | -903.86 717.44% | |||||||||
free cash flow per share | -8.32 - | -15.90 91.11% | -14.62 8.06% | -12.91 11.70% | -9.70 24.85% | -5.85 39.71% | -4.33 26.01% | -1.80 58.34% | -1.02 43.35% | 0.34 133.59% | -178.50 52,156.69% | |
free cash flow yield | -0.05 - | -0.09 91.11% | -0.15 67.66% | -0.49 225.95% | -0.49 0.91% | -0.50 3.37% | -0.66 31.53% | -0.23 65.12% | -0.17 26.48% | 0.03 118.95% | -35.14 109,234.60% | |
graham net net | -2.36 - | -3.04 28.70% | 16.53 643.75% | 9.90 40.10% | 5.72 42.21% | 2.15 62.45% | 0.65 69.82% | 4.82 642.93% | 3.45 28.39% | 2.54 26.55% | 118.82 4,587.18% | |
graham number | 25.64 - | 35.83 39.75% | 80.16 123.74% | 61.45 23.34% | 40.66 33.84% | 19.38 52.35% | 10.56 45.51% | 14.37 36.12% | 9.81 31.76% | 9.05 7.68% | 751.38 8,200.14% | |
income quality | 0.58 - | 0.58 0.49% | 0.88 51.75% | 0.85 3.09% | 0.81 5.21% | 0.87 7.33% | 0.98 12.69% | 0.97 0.71% | 0.84 13.44% | -0.26 131.08% | 0.97 470.36% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -2.63K - | -25.96K 887.66% | -3.16K 87.84% | -5.36K 69.91% | -4.96K 7.57% | -137.44 97.23% | 31.37 - | |||||
interest debt per share | 0.21 - | 0.31 47.50% | 0.22 31.03% | 0.00 98.56% | 0.00 21.26% | 0.12 4,953.47% | 0.29 132.71% | 0.06 78.81% | 0.02 75.22% | 0.06 310.60% | 7.94 12,734.15% | |
inventory turnover | ||||||||||||
invested capital | -0.10 - | -0.15 45.74% | 0.01 108.20% | 0.03 - | 0.25 749.13% | 0.01 95.24% | 0.00 64.98% | 0.04 821.05% | 0.06 49.61% | |||
market cap | 134.01M - | 161.17M 20.27% | 123.25M 23.53% | 42.40M 65.59% | 44.29M 4.45% | 41.04M 7.35% | 32.50M 20.81% | 94.65M 191.25% | 123.62M 30.61% | 257.11M 107.99% | 1.35M 99.47% | |
net current asset value | -1.57M - | -2.08M 32.51% | 21.87M 1,148.84% | 17.87M 18.28% | 13.17M 26.28% | 8.25M 37.35% | 4.06M 50.79% | 59.85M 1,373.45% | 72.91M 21.82% | 63.23M 13.27% | 33.20M 47.50% | |
net debt to ebitda | 0.82 - | 0.29 64.93% | 1.02 257.88% | 0.77 25.17% | 0.64 16.42% | 0.56 11.96% | 0.36 35.92% | 2.86 691.99% | 3.17 10.80% | 3.18 0.35% | 1.44 54.88% | |
net income per share | -14.21 - | -27.07 90.53% | -16.53 38.93% | -15.06 8.92% | -11.96 20.59% | -6.69 44.03% | -4.37 34.75% | -1.82 58.41% | -1.20 34.19% | -1.32 10.66% | -183.50 13,773.92% | |
operating cash flow per share | -8.30 - | -15.73 89.61% | -14.58 7.32% | -12.87 11.73% | -9.69 24.72% | -5.82 39.93% | -4.31 25.89% | -1.78 58.70% | -1.01 43.05% | 0.36 135.29% | -177.92 49,791.92% | |
payables turnover | 0.01 - | |||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | 15.76 - | 22.46 42.51% | 477.41 2,025.48% | |||||||||
return on tangible assets | -1.87 - | -3.26 74.55% | -0.79 75.75% | -1.08 36.52% | -1.45 34.37% | -1.59 9.51% | -1.86 17.19% | -0.33 82.17% | -0.31 7.86% | -0.28 8.57% | -0.60 114.36% | |
revenue per share | 0.06 - | 0.04 23.29% | 0.30 613.62% | |||||||||
roe | 6.91 - | 12.84 85.88% | -0.96 107.45% | -1.35 41.15% | -1.95 44.07% | -2.68 37.94% | -3.85 43.41% | -0.36 90.66% | -0.33 6.99% | -0.48 43.68% | -1.34 179.40% | |
roic | 4.70 - | 13.72 191.61% | -1.12 108.14% | -1.49 33.51% | -1.95 30.47% | -2.64 35.74% | -2.70 2.12% | -0.35 86.88% | -0.33 5.58% | -0.46 37.82% | -1.28 177.76% | |
sales general and administrative to revenue | 7.06 - | 11.65 65.00% | 164.58 1,312.76% | |||||||||
shareholders equity per share | -2.06 - | -2.11 2.50% | 17.28 919.64% | 11.15 35.47% | 6.14 44.88% | 2.49 59.42% | 1.13 54.50% | 5.05 345.47% | 3.58 29.24% | 2.75 22.98% | 136.74 4,865.60% | |
stock based compensation to revenue | 1.48 - | 2.71 83.26% | 47.43 1,647.94% | |||||||||
tangible asset value | -1.56M - | -1.92M 23.28% | 21.97M 1,242.98% | 18.01M 18.05% | 13.67M 24.08% | 8.81M 35.54% | 5.64M 35.95% | 61.32M 986.36% | 73.55M 19.94% | 66.48M 9.61% | 36.38M 45.28% | |
tangible book value per share | -2.06 - | -2.11 2.50% | 17.28 919.64% | 11.15 35.47% | 6.14 44.88% | 2.49 59.42% | 1.13 54.50% | 5.05 345.47% | 3.58 29.24% | 2.75 22.98% | 136.74 4,865.60% | |
working capital | -1.57M - | -2.08M 32.51% | 21.87M 1,148.84% | 17.87M 18.28% | 13.17M 26.28% | 8.27M 37.25% | 4.74M 42.61% | 60.16M 1,168.08% | 72.91M 21.20% | 100.31M 37.59% | 69.77M 30.45% |
All numbers in USD (except ratios and percentages)